From May 1^st to May 5^th, more than 11,000 people attended the Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting in Seattle, WA. Eye and vision researchers from more than 75 countries presented their current research, discussed emerging technologies, and strategized ways to overcome the current challenges facing ophthalmology and vision science. Harvard Ophthalmology was well-represented at the meeting, and faculty and trainees contributed 247 posters and presentations this year.

...

David M. Brown, MD, Clinical Professor of Ophthalmology at Cullen Eye Institute, Baylor College of Medicine, will present the inaugural Joan W. Miller Lecture, entitled "Pathophysiology of Retinal Vein Occlusion (RVO) - Revelations of the anti-VEGF Trials," today, Friday, April 15, 2016 at the New England Ophthalmological Society (NEOS) Annual Meeting at the Back Bay Event Center in Boston. The lectureship was endowed with a contribution from...

The free, full-text of the 2015 Association for Research in Vision and Ophthalmology (ARVO)/Champalimaud Award Lecture, “VEGF: From Discovery to Therapy,” is now available online. Joan W. Miller, MD, the Henry Willard Williams Professor and Chair of HMS Ophthalmology, presented this lecture at the 2015 ARVO Annual Meeting, and...

Joan W. Miller, MD, Henry Willard Williams Professor of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School (HMS), was appointed Treasurer of The Macula Society as of February 27, 2016. Dr. Miller is an internationally recognized expert on retinal disorders, including age-related macular degeneration (AMD), retinal degenerations, and diabetic retinopathy. Along with...

A phase I/II clinical trial at Massachusetts Eye and Ear found that some patients taking high doses of atorvastatin (cholesterol-lowering medication) had complete resolution of lipid deposits in the dry form of age-related macular degeneration (AMD). AMD is the leading cause of blindness in the developed world, and though effective treatments are available for the wet AMD, they are currently lacking for the more-prevalent dry form.

...

Six members of the Harvard Medical School Department of Ophthalmology were highlighted in the December 2015 issue of Boston Magazine as "Top Doctors." Included in this list are Reza Dana, MD, MSc, MPH, Joan...

The American Academy of Ophthalmology (AAO) is hosting its 2015 annual meeting at the Sands Expo/Venetian in Las Vegas, Nevada from November 14-17, 2015, with subspecialty days on November 13-14, 2015. 

Click here to view the HMS schedule for this event.

Don't miss the ...

BOSTON (October 19, 2015) -- Joan Whitten Miller, MD, Henry Willard Williams Professor of Ophthalmology and Chair of Ophthalmology at Harvard Medical School, and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, has been elected to membership in the prestigious National Academy of Medicine (NAM). Dr. Miller is an internationally recognized expert on retinal disorders, including age-related macular...

ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, has announced that Joan W. Miller, MD, Chair of the Department of Ophthalmology, Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, is one of five of the world’s premier retinal disease thought leaders who will serve on its newly formed scientific advisory board (SAB). The goal of...

Joan Miller was quoted in an article on the increase of AMD drugs in the past decade.

September 3, 2015 Investor's Business Daily

In the 2015 Annual Meeting of the the Association for Research in Vision and Ophthalmology (ARVO), HMS Ophthalmology faculty and trainees will present 255 abstracts, including 35 papers, 188 posters, 3 award lectures, 4 educational courses, 6 mini symposia, 8 special interest groups, 2 cross sectional group sessions, and 4 workshops. 

• ...

Retinal Disorders:
Genetic Approaches to Diagnosis and Treatment
Edited by Eric A. Pierce, Richard H. Masland, and Joan W. Miller

Cold Spring Harbor Laboratory Press announces the release of Retinal Disorders: Genetics Approaches to Diagnosis and Treatment, edited by Department of Ophthalmology faculty Eric A. Pierce,...

World-renowned scientific award, often called the "Nobel Prize of Vision," recognizes the groundbreaking development of anti-angiogenic therapy for retinal disease

Jump to:
About the 2014 Champalimaud Laureates
About the Champalimaud Foundation
Background | Videos | Photographs | ...

BOSTON (May 20, 2014) –Two prominent faculty members of the Harvard Medical School Department of Ophthalmology and Massachusetts Eye and Ear/Schepens Eye Research Institute were selected by the Association for Research in Vision and Ophthalmology (ARVO) to receive prestigious 2015 ARVO Achievement Awards. These honors were announced during the ARVO 2014 Annual Meeting held May 4 through 8 in Orlando, Florida.

Patricia D’Amore, PhD, MBA, FARVO, is...